Orion OyjORINF +4.81%100 Days Payable is 76.75 as of Mar. 2026, which is 5% above its 10-year median of 73.13. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $82.46. The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Orion Oyj ranks worse than 69.45% on this metric.
Orion Oyj's average Accounts Payable for the
three
months ended in Mar. 2026 was $159 Mil. Orion Oyj's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $189 Mil.
Hence, Orion Oyj's Days Payable for the
three
months ended in Mar. 2026 was 76.75.
The historical rank and industry rank for Orion Oyj's Days Payable or its related term are showing as below:
ORINF'
s Days Payable Range Over the Past 10 Years
Min: 56.81 Med: 73.13 Max: 88.8
Current: 57.37
During the past 13 years, Orion Oyj's highest Days Payable was 88.80. The lowest was 56.81. And the median was 73.13.
ORINF's Days Payable is ranked worse than 69.45% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs ORINF: 57.37
Orion Oyj's Days Payable
increased
from Mar. 2025 (51.97) to Mar. 2026 (76.75).
It may suggest that Orion Oyjdelayed paying its suppliers.
Orion Oyj Days Payable Related Terms
Orion Oyj Days Payable Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Orion Oyj's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Days Payable distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Orion Oyj's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Days Payable of 76.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Orion Oyj and its competitors. This is near median its historical median of 73.13. Over the past decade, Orion Oyj's Days Payable has ranged from 56.81 to 88.80. According to the industry distribution chart, Orion Oyj ranks #641 out of 923 companies in the Drug Manufacturers industry, placing it in the top 69.4%.
Is Orion Oyj's Days Payable too high?
Orion Oyj's current Days Payable of 76.75 is near median its 10-year median of 73.13. Over the past 10 years, this metric has ranged from a low of 56.81 to a high of 88.80. The Drug Manufacturers industry median Days Payable is 90.98. Orion Oyj's value of 76.75 is 15.6% below this industry median. Based on the distribution chart, Orion Oyj ranks #641 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #641 out of 923 companies for Days Payable. This places Orion Oyj in the lower half of its industry. The industry median Days Payable is 90.98. Orion Oyj's value of 76.75 is 15.6% below this benchmark. Historically, Orion Oyj's own Days Payable has ranged from 56.81 to 88.80 over the past decade. While the company's 10-year median is 73.13 vs. the industry median of 90.98, Orion Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Days Payable of 76.75 is 15.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Days Payable is 76.75, which is near median its own 10-year median of 73.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Days Payable of 76.75. The stock's GF Value™ is $82.46, compared to a current price of $82.75 — trading 0.4% above its estimated fair value. The current Days Payable is 76.75, which is near median its 10-year median of 73.13 and 15.6% below the Drug Manufacturers industry median of 90.98. Orion Oyj's overall GF Score™ is 100/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Days Payable is 76.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued.
The current stock price of $82.75 is trading 0.4% above its estimated GF Value™ of $82.46.
Key valuation signals for ORINF:
Days Payable: 76.75 (near median its 10-year median of 73.13)
GF Value™: $82.46 vs. price of $82.75 (0.4% above fair value)
Industry Position: 15.6% below the Drug Manufacturers median (#641 of 923)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
